• Reengineering Trials Is An Organizational Imperative

    Clinical Research News | In the space of a year, the clinical trials enterprise has made “a decade of progress” in the way it conducts studies, according to Harlan Krumholz, cofounder of Hugo Health, who spoke about participant-partnered research at the recent Summit for Clinical Ops Executives (SCOPE).

    Mar 18, 2021

  • How Active Safety Analytics Can Help Pharma Companies Increase Public Confidence in COVID-19 Vaccines

    Clinical Research News | The biggest US vaccine initiative is currently underway, with 32.3 million people having received at least one dose of either Pfizer-BioNTech or Moderna’s COVID-19 vaccine—including 37 million who have been fully vaccinated—as of the second week of March.

    Mar 17, 2021

  • Award-Winning Participant Engagement Strategies

    Clinical Research News | A lot of technology companies talk about the importance of patient input on the products they build, but Medidata is the first to hire patient advocates to provide feedback throughout the development life cycle—specifically, the patient cloud products it deploys in clinical trials, says Alicia Staley, senior director of patient engagement. “We’ve put a process in place to hold our own feet to the fire,” she says. “If our patient advocates haven’t looked at something rolling out the door, an explanation is expected as to why not.”

    Mar 16, 2021

  • How To Integrate The Patient Voice Into Trial Design

    Clinical Research News | The need to listen to the voice of patients at the right time, in the right context, and in their own language was a dominant theme of a live panel session at the recent Summit for Clinical Ops Executives (SCOPE) where views were shared on integrating patient insights into clinical trial design.

    Mar 15, 2021

  • Clinical Control Tower Providing Near-Real-Time View Of GSK Trials

    Clinical Research News | Thanks to COVID-19, asset leads at GlaxoSmithKline (GSK) can now tap a Clinical Control Tower for answers to five critical questions about how studies are progressing and if they are veering off course. The platform was developed last year to enable trial leaders to maintain business continuity during the pandemic.

    Mar 12, 2021

  • Antibodies Plus Vaccines, RWD on Post-Shot Reactions: COVID-19 Updates

    Clinical Research News | Top COVID-19 news and research stories of the week: real-world data from Mass General Brigham staff after vaccination, antibodies and the jab, and springtime impacts on infection rates.

    Mar 12, 2021

  • SCOPE 2021 Highlights New Value Props From Vendors

    Clinical Research News | New products, acquisitions, and a Cannes Film Festival award—some of the noteworthy announcements heard on the virtual exhibit hall floor during SCOPE 2021.

    Mar 11, 2021

  • Janssen Lost Little Ground on Trials Due To COVID-19

    Clinical Research News | Many of the process-related changes Janssen made in response to COVID-19—including virtual investigator meetings, analytic risk-based monitoring (ARBM), and direct-to-participant clinical trial approaches—will endure beyond the pandemic.

    Mar 10, 2021